Increasing The Accuracy Of Multiple Sclerosis Relapse Monitoring Olink Proteomics Ms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In the Relapsing-Remitting form of Multiple Sclerosis (RRMS), a single biomarker (soluble neurofilament light chain or sNfL) is identified as a biomarker for inflammatory activity in MS, but is limited in its ability to identify relapses. Through screening several hundred proteins using Olink ® technology, three additional protein biomarkers have been identified as an improved relapse-specific signature to monitor disease activity in RRMS patients. ....

United States , Ferhan Qureshi , Olink Cardiometabolic , Oklahoma Medical Research Foundation , Biomarker Product Development Of Octave , Stanford University , Industry News , Multiple Sclerosis , Epstein Barr Virus , Operating Characteristics , Biomarker Product Development , Mult Scler Relat , Increasing The Accuracy Of Multiple Sclerosis Relapse Monitoring Olink Proteomics Ms , Multiple Sclerosis , Olink Proteomics , Protein Biomarker ,